Department of Pathology

ABMGG Clinical Molecular Genetics and Clinical Cytogenetics Fellowship Program

Program Director and Contact:


Rizwan C. Naeem, MBBS, FACMG
Professor of Pathology
Director MGP and ABMG Lab Genetics Fellowship Programs;
Director Molecular Pathology
Albert Einstein College of Medicine and
Montefiore Medical Center
111 East 210th Street, RT5, Room 504
Bronx, NY 10467
Phone: 718-920-6198
Cell: 917-647-4961
Fax: 718-920-2927
Genetics Fellowship
Molecular Genetic Pathology Fellowship  

Program Description

Overview and Objectives 

This Two-Year Modified ABMGG Fellowship Program in Medical Genetics and Genomics will train individuals with either a Ph.D. in genetics or a M.D. and residency in pathology or medical genetics to become the next generation of diagnostic geneticists with an extensive knowledge and expertise in traditional and modern genetics and genomics. Each Fellow will be prepared to direct a molecular and/or cytogenics diagnostic laboratory. 

Fellowship training includes didactic sessions, active involvement in clinical case sign out, training in laboratory bench work associated with research or development projects, and participation in medical genetics clinics and teaching conferences in medical genetics. The training encompasses all aspects of medical genetics (i.e. clinical genetics, genetic counseling and biochemical genetics).

The Fellowship program will have extensive resources of the Department of Pathology and broad-based teaching and research collaboration from Pediatrics, OB/GYN and Genetics. It is designed to provide high quality educational experiences in the training of genetic laboratory specialists. Our faculty consists of many board certified geneticists and board certified genetic counselors. 

  • Clinical Cytogenetics is a laboratory-based specialty of medical genetics that involves the processing and analysis of the chromosomes of various types of samples with the express purpose of detecting and interpreting chromosomal abnormalities using various methodologies.  Clinical Cytogenetics is recognized as a primary specialty by the American Board of Medical Specialists (ABMS).
  • Clinical Molecular Genetics is a laboratory-based specialty of medical genetics that focuses on the discovery of and laboratory testing for DNA mutations that underlie disease. Clinical Molecular Genetics is recognized as a primary specialty by the ABMS. Fellow will be trained in both traditional and modern diagnostic platform.

The program accepts one candidate in two years. Applicants are eligible with either a Ph.D. in genetics or a M.D. and residency in Pathology or medical genetics. Individuals with a M.D. or Ph.D. earned outside the United States or Canada must have their degree reviewed by the ABMG Credentials Committee prior to entering a training program.

For information on degree review procedures please visit American Board of Molecular Genetics.

Application and Materials
Applications are accepted year-round, with open dates to start. There is no deadline and interviews are granted based upon review of the application package.

Materials required for application are:

  • Candidate’s CV
  • Personal Goals Statement
  • Transcripts
  • Three Letters of Recommendation
  • Wallet-Sized Color Photo

Financial Support
Financial support is available from the Department of Pathology clinical laboratory program.  Fellow will receive standard stipend and benefits from Department of Pathology at Montefiore Medical Center. Self-funding via granting institutes and organizations is also considered.

The Molecular Pathology Laboratory at Einstein and MMC offers a broad menu of molecular/genetic testing in the areas of hematopathology/oncology, microorganism detection, genetics, genomics, pharmacogenetics and engraftment monitoring.

The laboratory is a CLIA, CAP and New York State accredited regional reference laboratory in the Bronx and upper northern Westchester County of New York. The techniques used in the laboratory range from traditional DNA extraction and hybridization methods to the state-of-the-art technologies, including DNA sequencing, quantitative PCR, DNA fragment analysis by capillary electrophoresis, array CGH and microarray.


See also:

Click here to log in